Drug Pipeline

BMS-986489 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
1
Phase 3
2
Top Sponsors
Active Studies by Phase
Phase 3
1
Phase 2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06646276 A Study to Compare the Efficacy and Safety of BMS-986489 (BMS-986012+ Nivolumab Fixed… Extensive-Stage Small Cell Lung Cancer Recruiting
Phase 2
NCT06773910 BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer… Limited Stage Small Cell Lung Cancer Recruiting
Phase 1
NCT06799286 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy… Small Cell Lung Carcinoma Active, Not Recruiting
Sponsors Running BMS-986489 Trials
Bristol-Myers Squibb (2) SCRI Development Innovations, LLC (1)
Disease Areas
Small Cell Lung Cancer (3) Lung Cancer (3)
Get alerts when BMS-986489 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free